Company Profile

ALS Limited

ALQ · AU
Other listingsALQ · AX
Industry
Testing & Certification Services
Exchange
AU
Price at Publication
23.36
Jun 18, 2026 close
Fair Buy
≤ 16
Margin-of-safety entry
Baillie Growth Score
46/100
Weak
Intrinsic Value · Three-Tier Range Price at publication 23.36 · Within the fair intrinsic-value range

Composite valuation range · conservative 14.5–16 / fair 20.5–27.5 / optimistic 32.5–35. At the publication price of 23.36 (Jun 18, 2026), Within the fair intrinsic-value range.

About the company

Company overview coming soon.

Background

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

Research on this stock
46/100 Hold ALS Limited: A High-Quality Compounder with a Cyclical Sidecar ALS Limited is a global laboratory-testing group that earns most of its revenue from Life Sciences yet a disproportionate share of margin from minerals-related Commodities testing, so a diversified TIC provider still trades, at key moments, like a high-quality miner's service proxy. FY26 delivered record revenue of A$3.32 billion and an 18.0% underlying EBIT margin, hitting the FY27 strategic targets a year early, but at A$23.36 the stock trades near 37 times trailing EPS with the margin of safety put at zero. Rating Hold: a strong dual-engine testing franchise whose price already discounts commodities strength, acquisition repair and future hub productivity, leaving little room for disappointment. ALS LimitedALQ · AUTesting & Certification ServicesJun 18, 2026